TrialLower urinary tract symptoms2024

Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL).

Narihito Seki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.